Below is Validea's guru fundamental report for MODERNA INC (MRNA). Of the 22 guru strategies we follow, MRNA rates highest using our Value Investor model based on the published strategy of Benjamin ...
(MENAFN- iCrowdNewsWire) Latest Study on Industrial Growth of Worldwide MRNA Vaccine And Therapeutics Market 2021-2027. A detailed study accumulated to offer Latest insights about acute features of ...
Dublin, Aug. 11, 2025 (GLOBE NEWSWIRE) -- The "mRNA Synthesis Raw Materials - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for mRNA ...
Fintel reports that on November 10, 2025, B of A Securities maintained coverage of Moderna (NasdaqGS:MRNA) with a ...
V Square Quantitative Management LLC increased its stake in Moderna, Inc. (NASDAQ:MRNA – Free Report) by 34.8% in the 2nd quarter, according to the company in its most recent filing with the SEC. The ...
Dublin, Aug. 12, 2025 (GLOBE NEWSWIRE) -- The "Neoantigen Cancer Vaccine Market by Neoantigen Type (Personalized Neoantigens, Shared Neoantigens), Therapeutic Target (Immune Checkpoint Blockade, Tumor ...
The US Department of Health and Human Services (HHS) plans to cancel $500m (£376m) in funding for mRNA vaccines being developed to counter viruses that cause diseases such as the flu and Covid-19.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback